ข่าวประชาสัมพันธ์ rheumatoid arthritis+Astellas Pharma Inc
Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf(R) in Taiwan and select South-East Asian markets
Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf(R) 50 mg and 100 mg Tablets (generic name: peficitinib hydrobromide) in Taiwan for the treatment of rheumatoid arthritis. Smyraf(R) has been approved in Taiwan and has patent protection for composition of matter until 2032. Subject to the terms of the
เมนารินี เอเชีย-แปซิฟิก ลงนามข้อตกลงร่วมกับแอสเทลลัส ขึ้นแท่นผู้จำหน่ายยาสไมราฟแต่เพียงผู้เดียวในตลาดไต้หวันและเอเชียตะวันออกเฉียงใต้บางแห่ง
เมนารินี เอเชีย-แปซิฟิก (Menarini Asia-Pacific) ได้ลงนามในสัญญาอนุญาตให้ใช้สิทธิโดยเด็ดขาดระยะยาวร่วมกับแอสเทลลัส ฟาร์มา อิงค์ (Astellas Pharma Inc.) หรือ แอส...Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign for Women with Chronic Inflammatory Diseases
- Grand Slam winner Caroline Wozniacki is the highest-ranking female athlete known to have been diagnosed with rheumatoid arthritis whilst still playing professional tennis -...Zydus Launches World’s First Biosimilar of Adalimumab
Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosing Spondylitis in India After more than a decade-long wait, the...Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)
Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business Coherus BioSciences, Inc. announced the start of its...Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis
Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an...
“Marinated shredded chicken with jelly fish served cold” @ Yok Chinese Restaurant
—
Yok Chinese Restaurant of the Emerald Hotel would like to invite you t...